Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Hunder

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Arthritis and Rheumatism|December 1, 1985
Seronegative polyarthritis in giant cell arteritisW W Ginsburg, M D Cohen, S B Hall, et al.
Lancet (London, England)|November 26, 1983
The therapeutic impact of temporal artery biopsyS Hall, S Persellin, J T Lie, et al.
Arthritis and Rheumatism|June 12, 1999
The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluationS E Gabriel, M Espy, D D Erdman, et al.
Medicine|March 1, 1985
Takayasu arteritis. A study of 32 North American patientsS Hall, W Barr, J T Lie, et al.
Arthritis and Rheumatism|November 1, 1994
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumaticaC Salvarani, S E Gabriel, M A Gertz, et al.
Arthritis and Rheumatism|October 1, 1990
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disordersM A Kotowicz, S Hall, G G Hunder, et al.
Arthritis and Rheumatism|September 1, 1993
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritisN E Roche, J W Fulbright, A D Wagner, et al.
The Journal of Rheumatology|June 1, 1995
Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled studyB H Littman, D Bjarnason, G Bryant, et al.
Rheumatic Diseases Clinics of North America|November 29, 2001
Vasculitis. A collection of pearls and mythsJ H Stone, L H Calabrese, G S Hoffman, et al.
Mayo Clinic Proceedings|July 1, 1985
Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumaticaS T Persellin, T M Daniels, L J Rings, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Arthritis and Rheumatism|December 1, 1985
Seronegative polyarthritis in giant cell arteritisW W Ginsburg, M D Cohen, S B Hall, et al.
Lancet (London, England)|November 26, 1983
The therapeutic impact of temporal artery biopsyS Hall, S Persellin, J T Lie, et al.
Arthritis and Rheumatism|June 12, 1999
The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluationS E Gabriel, M Espy, D D Erdman, et al.
Medicine|March 1, 1985
Takayasu arteritis. A study of 32 North American patientsS Hall, W Barr, J T Lie, et al.
Arthritis and Rheumatism|November 1, 1994
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumaticaC Salvarani, S E Gabriel, M A Gertz, et al.
Arthritis and Rheumatism|October 1, 1990
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disordersM A Kotowicz, S Hall, G G Hunder, et al.
Arthritis and Rheumatism|September 1, 1993
Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritisN E Roche, J W Fulbright, A D Wagner, et al.
The Journal of Rheumatology|June 1, 1995
Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled studyB H Littman, D Bjarnason, G Bryant, et al.
Rheumatic Diseases Clinics of North America|November 29, 2001
Vasculitis. A collection of pearls and mythsJ H Stone, L H Calabrese, G S Hoffman, et al.
Mayo Clinic Proceedings|July 1, 1985
Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumaticaS T Persellin, T M Daniels, L J Rings, et al.
Pageof 17